Literature review evaluates the potential of menstrual blood-derived stem cells enhanced by nanobiotechnology, suggesting innovative pathways for regenerative medicine.
This independent literature review examines the relation between nanobiotechnology and menstrual blood-derived stem cells (MenSCs) to evaluate their combined potential in transforming regenerative medicine. While MenSCs represent a highly accessible source of stem cells, integrating them with advanced nanomaterials offers a promising future for enhanced tissue engineering. This paper synthesizes current breakthroughs regarding the importance of menstrual blood in research and explores how future nanotechnology applications can optimize these cells for clinical use. This work highlights emerging, non-invasive solutions in modern biomedical science.
No takes yet. Share an insight, caveat, or question.
Kashaf Fawad (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: